Exploring Tumor Microenvironment and Vascular Changes — Insights from Dr. Aliyarbayova Aygun Aliyar

Exploring Tumor Microenvironment and Vascular Changes — Insights from Dr. Aliyarbayova Aygun Aliyar



Understanding the microscopic and ultrastructural changes within tissues is essential for advancing cancer research and improving therapeutic strategies. At the 12th International Cancer, Oncology and Therapy Conference and Exhibition, we are honored to feature Dr. Aliyarbayova Aygun Aliyar, Assistant Professor in the Department of Cytology, Embryology, and Histology at Azerbaijan Medical University, Azerbaijan.

Dr. Aliyar will present her research through a scientific poster titled: “Ultrastructural Study of Changes in the Pulmonary Vascular Compartments under Macrophage Migration Inhibitory Factor (MIF).”

Investigating the Role of MIF in Pulmonary Tissue Dynamics

Macrophage Migration Inhibitory Factor (MIF) is a key inflammatory cytokine increasingly recognized for its role in cancer biology, tumor progression, angiogenesis, and immune regulation. By examining how MIF interacts with lung structural elements, researchers can gain deeper insight into how inflammatory mediators influence vascular compartments and tissue remodeling—processes closely linked to cancer metastasis and tumor microenvironment development.

Dr. Aliyar’s work focuses on the ultrastructural level, providing highly detailed observations that contribute to understanding how cellular and vascular alterations occur under MIF influence. Such findings are crucial for identifying potential diagnostic markers and therapeutic targets, particularly in cancers involving pulmonary involvement or metastatic spread.

A Career Dedicated to Morphological and Translational Research

Dr. Aliyarbayova Aygun Aliyar completed her PhD at Azerbaijan Medical University and has been actively engaged in postdoctoral research since 2022, concentrating on the interaction between macrophage migration inhibitory factor and lung structural elements. Her academic work bridges classical histological science with modern oncological research, strengthening the understanding of disease mechanisms at a cellular and molecular level.

Currently serving as an Assistant Professor, she contributes to education and research in cytology, embryology, and histology, mentoring future medical scientists while advancing investigative pathology.

Significant Contributions to Scientific Literature

Dr. Aliyar is an active member of the Azerbaijan Anatomy, Embryology and Histology Society and has authored more than 100 publications in reputable journals and conference proceedings. Her extensive scholarly output reflects a sustained commitment to advancing biomedical knowledge and collaborative research.

Why This Research Matters for Oncology

Studying structural and vascular alterations provides essential insights into:

  • Tumor microenvironment evolution

  • Inflammatory mediators influencing cancer progression

  • Mechanisms of angiogenesis and tissue remodeling

  • Potential pathways for targeted therapeutic intervention

  • Translational links between morphology and clinical oncology

Research such as Dr. Aliyar’s helps connect foundational cellular science with practical oncological applications, reinforcing the multidisciplinary nature of modern cancer research.

Join Us in Dubai

The 12th International Cancer, Oncology and Therapy Conference and Exhibition will bring together global experts to share discoveries that are shaping the future of cancer diagnosis, treatment, and prevention.

📅 April 09–11, 2026 📍 Novotel Dubai Al Barsha, Dubai, UAE

We look forward to welcoming participants to engage with cutting-edge research, collaborative discussions, and scientific advancements that continue to redefine oncology.

#CancerUCG2026 #OncologyConference #CancerResearch #TumorMicroenvironment #MIF #PathologyResearch #Histology #Cytology #TranslationalResearch #CancerScience #MedicalResearch #PulmonaryResearch #Angiogenesis #ScientificInnovation #OncologyCommunity #HealthcareResearch #DubaiConference #FutureOfCancerResearch

Comments

Post a Comment

Popular posts from this blog

Nursing Innovation in Oncology: Advancing Patient-Centered Cancer Care

Image
  Nursing Innovation in Oncology: Advancing Patient-Centered Cancer Care 11th International Cancer, Oncology and Therapy Conference 📍 Dubai, UAE | 📅 September 02–04, 2025 In the ever-evolving world of oncology, the role of nurses has expanded far beyond conventional caregiving. Today’s oncology nurses are pivotal in driving innovation, advocating for patients, and delivering care that is not only clinically effective but also emotionally responsive and culturally competent. As we look ahead to the 11th International Cancer, Oncology and Therapy Conference (ICOT 2025) in Dubai, UAE , it is imperative to shine a light on the transformative power of nursing innovation in advancing patient-centered cancer care . 🌟 The Evolving Role of the Oncology Nurse Oncology nursing has undergone a significant transformation in the past decade. No longer confined to hospital wards or chemotherapy units, oncology nurses are now active contributors in clinical trials, digital healt...
Read more

The Role of Immunotherapy in Advanced Liver Cancer

Image
  The Role of Immunotherapy in Advanced Liver Cancer 11th International Cancer, Oncology and Therapy Conference | September 02-04, 2025 | Dubai, UAE & Online https://cancer.utilitarianconferences.com Introduction Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the most challenging malignancies worldwide due to its asymptomatic nature in early stages, limited treatment options, and poor prognosis in advanced stages. While traditional treatments such as surgery, chemotherapy, and targeted therapies have provided limited success in advanced cases, immunotherapy has emerged as a beacon of hope for transforming the treatment landscape. As we prepare for the 11th International Cancer, Oncology and Therapy Conference (11CANCERUCG2025) , held from September 02–04, 2025 in Dubai, UAE , leading researchers, oncologists, and healthcare professionals will gather to explore cutting-edge developments in cancer care — with a major focus on revolutionizing ...
Read more

Public Health Strategies for Reducing Cancer Mortality

Image
  Exploring Breakthroughs at the 11th International Cancer, Oncology, and Therapy Conference The global fight against cancer continues to evolve with groundbreaking research, innovative therapies, and collaborative efforts that bring hope to millions. This year, the 11th International Cancer, Oncology, and Therapy Conference is set to take place in Abu Dhabi, UAE, from September 2-4, 2025. This prestigious event will bring together leading oncologists, researchers, and healthcare professionals from around the world to discuss the latest advancements in cancer treatment and care. A Hub for Innovation and Collaboration The conference serves as a dynamic platform where experts from diverse fields of oncology can exchange ideas, present research findings, and explore cutting-edge treatments. The event will cover a broad spectrum of topics, including: Advances in Immunotherapy: New frontiers in CAR-T cell therapy and immune checkpoint inhibitors. Personalized Medicine: The role of genom...
Read more